AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Meropenem Trihydrate USP
5 registrations across 3 African markets— 5 active
Markets with Meropenem Trihydrate USP
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Zaxter 1 g Injection Powder For Injection | 🇰🇪Kenya | Alkem Laboratories | active | Mar 2031 |
| Ameropem 0.5g POWDER FOR SOLUTION FOR INJECTION OR INFUSION | 🇷🇼Rwanda | PHARCO B INTERNATIONAL | active | Sept 2030 |
| Mepran - 1000 IV injection Powder for Injection | 🇿🇲Zambia | Kopran Limited | active | Sept 2030 |
| MEROGLAX 500MG Powder For Injection | 🇰🇪Kenya | GALAXY PHARMACEUTICAL LIMITED | active | May 2029 |
| MEROGLAX 1GM Powder For Injection | 🇰🇪Kenya | GALAXY PHARMACEUTICAL LIMITED | active | Feb 2028 |
Meropenem Trihydrate USP in Africa — Regulatory Overview
Meropenem Trihydrate USP is registered across 3 African markets with 5 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Kenya, Rwanda, Zambia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 5 registrations, 5 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.